12/2
04:30 pm
sonn
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
High
Report
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
12/2
09:17 am
sonn
Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Proposed Business Combination with Hyperliquid Strategies Inc
High
Report
Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Proposed Business Combination with Hyperliquid Strategies Inc
11/18
07:06 pm
sonn
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting [Yahoo! Finance]
Medium
Report
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting [Yahoo! Finance]
11/18
09:00 am
sonn
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting
Medium
Report
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting
10/15
10:03 am
sonn
Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma
High
Report
Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma
9/19
09:36 am
sonn
Sonnet to Present at the MedInvest Biotech & Pharma Conference [Yahoo! Finance]
Low
Report
Sonnet to Present at the MedInvest Biotech & Pharma Conference [Yahoo! Finance]
9/19
09:00 am
sonn
Sonnet to Present at the MedInvest Biotech & Pharma Conference
High
Report
Sonnet to Present at the MedInvest Biotech & Pharma Conference